Squarepoint Ops LLC Supernus Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$99.2 Billion
Q4 2024

A detailed history of Squarepoint Ops LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 20,492 shares of SUPN stock, worth $686,891. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,492

Previous 20,967 2.27%

Holding current value

$686,891

Previous $653,000 13.32%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$31.89 - $37.83 $15,147 - $17,969	-475 Reduced 2.27%	20,492 $740,000
Q3 2024 Nov 14, 2024	BUY	$25.77 - $35.16 $540,319 - $737,199	20,967 New	20,967 $653,000
Q2 2023 Aug 14, 2023	BUY	$29.91 - $38.73 $95,682 - $123,897	3,199 Added 25.68%	15,655 $470,000
Q1 2023 May 15, 2023	SELL	$34.93 - $42.03 $694,687 - $835,892	-19,888 Reduced 61.49%	12,456 $451,000
Q4 2022 Feb 14, 2023	SELL	$31.09 - $37.88 $264,202 - $321,904	-8,498 Reduced 20.81%	32,344 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $1.18 Million - $1.45 Million	40,842 New	40,842 $1.38 Million
Q2 2022 Aug 15, 2022	SELL	$25.33 - $34.25 $349,174 - $472,136	-13,785 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$28.51 - $32.9 $578,952 - $668,100	-20,307 Reduced 59.57%	13,785 $446,000
Q4 2021 Feb 14, 2022	BUY	$26.37 - $34.22 $899,006 - $1.17 Million	34,092 New	34,092 $994,000
Q2 2021 Aug 16, 2021	SELL	$26.72 - $33.19 $608,254 - $755,537	-22,764 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$24.15 - $31.45 $210,322 - $273,898	8,709 Added 61.96%	22,764 $596,000
Q4 2020 Feb 16, 2021	SELL	$17.7 - $25.81 $409,436 - $597,036	-23,132 Reduced 62.2%	14,055 $354,000
Q3 2020 Nov 16, 2020	SELL	$20.2 - $25.05 $495,788 - $614,827	-24,544 Reduced 39.76%	37,187 $775,000
Q2 2020 Aug 14, 2020	BUY	$17.09 - $24.89 $27,737 - $40,396	1,623 Added 2.7%	61,731 $1.47 Million
Q1 2020 May 15, 2020	SELL	$14.45 - $24.69 $417,937 - $714,108	-28,923 Reduced 32.49%	60,108 $1.08 Million
Q4 2019 Feb 14, 2020	BUY	$19.93 - $29.13 $788,809 - $1.15 Million	39,579 Added 80.04%	89,031 $2.11 Million
Q3 2019 Nov 14, 2019	BUY	$25.47 - $33.37 $966,026 - $1.27 Million	37,928 Added 329.12%	49,452 $1.36 Million
Q2 2019 Aug 14, 2019	SELL	$29.96 - $38.87 $1.52 Million - $1.97 Million	-50,621 Reduced 81.46%	11,524 $381,000
Q1 2019 May 15, 2019	BUY	$32.77 - $41.99 $1.44 Million - $1.84 Million	43,843 Added 239.55%	62,145 $2.18 Million
Q4 2018 Feb 14, 2019	BUY	$30.84 - $49.51 $26,707 - $42,875	866 Added 4.97%	18,302 $608,000
Q3 2018 Nov 14, 2018	BUY	$42.7 - $56.55 $744,517 - $986,005	17,436 New	17,436 $878,000
Q2 2018 Aug 14, 2018	SELL	$44.1 - $59.85 $2.49 Million - $3.39 Million	-56,569 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$37.15 - $46.9 $1.75 Million - $2.21 Million	47,122 Added 498.8%	56,569 $2.59 Million
Q4 2017 Feb 14, 2018	SELL	$36.4 - $42.6 $1.56 Million - $1.82 Million	-42,729 Reduced 81.89%	9,447 $376,000
Q3 2017 Nov 14, 2017	BUY	$36.75 - $49.65 $1.92 Million - $2.59 Million	52,176	52,176 $2.09 Million

Others Institutions Holding SUPN

# of Institutions

303

Shares Held

60.6M

Call Options Held

22.3K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.79B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Supernus Pharmaceuticals, Inc. Transaction History